Table 2.

Main characteristics of patients with APL enrolled in this follow-up study compared with those who could not be enrolled for any reason

Variables at APL diagnosisPatients with APL analyzed in current study (n = 161)Patients with APL not enrolled in this study (n = 70)P value
Age at diagnosis, y   .075 
 Mean (SD) 46.4 (14.4) 42.6 (14.8)  
 Median (IQR) 47.0 (36.7-57.7) 41.9 (29.4-55.7)  
Sex, n (%)   
 Male 79 (49.1) 34 (48.6)  
 Female 82 (50.9) 36 (51.4)  
Randomization arm, n (%)   .320 
ATRA-ATO 83 (51.5) 31 (44.3)  
ATRA chemotherapy 78 (48.5) 39 (55.7)  
WBC count, ×109/L)   .059 
 Mean (SD) 2.1 (2.2) 2.4 (2.1)  
 Median (IQR) 1.2 (0.8-2.3) 1.7 (1.0-3.0)  
Platelet count, ×109/L)   .705 
 Mean (SD) 50.3 (45.2) 46.5 (41.6)  
 Median (IQR) 34.0 (18.0-64.0) 32.0 (19.0-53.0)  
Hemoglobin level, g/dL   .552 
 Mean (SD) 9.5 (2.1) 9.3 (2.0)  
 Median (IQR) 9.2 (8.3-11.0) 9.2 (8.0-11.1)  
Risk level, n (%)   
 Low 68 (43.3) 30 (42.9)  
 Intermediate 89 (56.7) 40 (57.1)  
 Missing 4 (.) 0 (.)  
Variables at APL diagnosisPatients with APL analyzed in current study (n = 161)Patients with APL not enrolled in this study (n = 70)P value
Age at diagnosis, y   .075 
 Mean (SD) 46.4 (14.4) 42.6 (14.8)  
 Median (IQR) 47.0 (36.7-57.7) 41.9 (29.4-55.7)  
Sex, n (%)   
 Male 79 (49.1) 34 (48.6)  
 Female 82 (50.9) 36 (51.4)  
Randomization arm, n (%)   .320 
ATRA-ATO 83 (51.5) 31 (44.3)  
ATRA chemotherapy 78 (48.5) 39 (55.7)  
WBC count, ×109/L)   .059 
 Mean (SD) 2.1 (2.2) 2.4 (2.1)  
 Median (IQR) 1.2 (0.8-2.3) 1.7 (1.0-3.0)  
Platelet count, ×109/L)   .705 
 Mean (SD) 50.3 (45.2) 46.5 (41.6)  
 Median (IQR) 34.0 (18.0-64.0) 32.0 (19.0-53.0)  
Hemoglobin level, g/dL   .552 
 Mean (SD) 9.5 (2.1) 9.3 (2.0)  
 Median (IQR) 9.2 (8.3-11.0) 9.2 (8.0-11.1)  
Risk level, n (%)   
 Low 68 (43.3) 30 (42.9)  
 Intermediate 89 (56.7) 40 (57.1)  
 Missing 4 (.) 0 (.)  

or Create an Account

Close Modal
Close Modal